Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

NCT05481827 is registered in ClinicalTrials.gov with Gyroscope Therapeutics Limited as lead sponsor.

NCT NCT05481827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05481827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Lead sponsor
Gyroscope Therapeutics Limited
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
July 12, 2022
Completion date
June 2, 2028
Enrollment
225 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration (amd)